VALISURE ANNOUNCES NEW VENTURE PARTNERS AND EXPANSION OF LEADERSHIP TEAM
NEW HAVEN, Conn., Feb. 28, 2024 /PRNewswire/ -- Valisure, a healthcare industry pioneer for independent quality assurance in pharmaceutical drugs, has recently received substantial investments from leading healthcare venture capital firms to accelerate Valisure's rapid growth and impact. Concurrently, the company is pleased to announce key leadership developments, including appointing a highly experienced healthcare leader as CEO and additional expansion of its executive team.
- Concurrently, the company is pleased to announce key leadership developments, including appointing a highly experienced healthcare leader as CEO and additional expansion of its executive team.
- Valisure has gained global recognition for its commitment to ensuring the safety and quality of medications through its highly impactful, independent testing.
- "I look forward to collaborating with the talented team and enabling Valisure to expand its work with the industry to strategically address these issues."
- Likewise, Wolfgang Hinz, Ph.D., has assumed a pivotal leadership position as the Chief Scientific Officer of Valisure.